Vivaldis Condrovet Force HA Medium Breed | Joint Care Supplement with Hyaluronic Acid, Glucosamine & Chondroitin

Dietary supplement for dogs — not a veterinary medicine. For use as a joint health nutritional supplement under veterinary guidance. Administer as directed by a licensed veterinarian based on dog body weight and clinical condition. Keep out of reach of children. Store in a cool, dry place away from direct sunlight; reseal packaging after use.

Vivaldis Condrovet Force HA Medium Breed Joint Care Supplement for Dogs (10 Tablets per Strip)

Vivaldis Condrovet Force HA Medium Breed is a precision-formulated veterinary joint care dietary supplement tablet for medium breed dogs, combining five clinically validated joint-supportive actives: Glucosamine HCl, Chondroitin Sulphate, Hyaluronic Acid Mobilee®, Native Type II Collagen b-2Cool®, and Vitamin E. This advanced joint supplement supports cartilage structure, synovial fluid viscosity, joint collagen integrity, and antioxidant protection in medium breed dogs with osteoarthritis, hip and elbow dysplasia, degenerative joint disease, and age-related joint mobility decline. Confirm complete composition and tablet count per strip from the Vivaldis Condrovet Force HA Medium Breed product label.

Composition (per tablet — confirm from product label)

• Glucosamine HCl (purity >99%): Amino monosaccharide precursor and rate-limiting substrate for glycosaminoglycan (GAG) biosynthesis in articular cartilage chondrocytes; provides the substrate for proteoglycan extracellular matrix (ECM) replenishment in osteoarthritic joints where chondrocyte synthetic capacity is impaired; additionally inhibits NF-κB signalling, reducing chondrocyte production of pro-inflammatory cytokines (IL-1β, TNF-α) and matrix metalloproteinases (MMPs) that degrade cartilage ECM
• Chondroitin Sulphate (purity 100%): Sulphated glycosaminoglycan (GAG) and structural component of the aggrecan proteoglycan of articular cartilage; provides osmotic swelling pressure and compressive load-bearing capacity via negatively charged sulphate groups; inhibits catabolic enzymes (aggrecanase ADAMTS-4/ADAMTS-5, MMP-3/MMP-13); inhibits IL-1β-mediated chondrocyte apoptosis; anti-inflammatory via NF-κB inhibition and reduction of synovial prostaglandin E2; synergistic with Glucosamine for proteoglycan synthesis and cartilage ECM maintenance
• Hyaluronic Acid Mobilee®: Patented high-molecular-weight hyaluronic acid concentrate from rooster comb; provides synovial fluid viscoelastic properties for joint lubrication and shock absorption; stimulates synoviocyte HA synthesis and increases synovial fluid HA concentration and molecular weight; supports chondrocyte proteoglycan synthesis via CD44 receptor signalling; confirm mg per tablet from product label
• Native Type II Collagen b-2Cool®: Patented native (undenatured) type II collagen from chicken sternum cartilage; activates oral tolerance via gut-associated lymphoid tissue (GALT) and Peyer's patches; Treg lymphocyte activation suppresses local immune-mediated cartilage collagen degradation in joints; the native (undenatured) form is essential for oral tolerance activation; confirm mg per tablet from product label
• Vitamin E (DL-α-tocopherol acetate 50%): Fat-soluble antioxidant; neutralises reactive oxygen species (ROS) and oxidative stress in joint tissues; protects chondrocyte mitochondrial membranes from oxidative damage and apoptosis; terminates lipid peroxidation chain reactions in articular cell membranes; confirm mg per tablet from product label

Therapeutic Class

• Veterinary nutraceutical / dietary supplement — joint health, cartilage support, synovial fluid maintenance, articular collagen integrity, and antioxidant joint protection for medium breed dogs

Key Benefits

• Cartilage structural support — Glucosamine HCl + Chondroitin Sulphate provide substrate and structural GAG components for articular cartilage proteoglycan matrix maintenance and repair
• Synovial fluid viscosupplementation — Hyaluronic Acid Mobilee stimulates synoviocyte HA synthesis, restoring synovial fluid viscosity, lubrication, and shock absorption
• Articular collagen preservation — Native Type II Collagen b-2Cool activates oral tolerance via GALT/Peyer's patches, suppressing immune-mediated cartilage collagen degradation
• Anti-inflammatory and anti-catabolic — Glucosamine and Chondroitin inhibit NF-κB, MMP, aggrecanase, and pro-inflammatory cytokine activity
• Antioxidant joint protection — Vitamin E neutralises ROS and oxidative stress in joint tissues
• Joint mobility and comfort — multi-modal joint support across cartilage, synovial fluid, collagen, and antioxidant pathways

Indications

• Osteoarthritis (OA) and degenerative joint disease (DJD) in medium breed dogs
• Hip dysplasia (HD) — joint care support in medium breed dogs
• Elbow dysplasia (ED) — cartilage and synovial fluid support
• Age-related joint mobility decline in medium breed senior dogs
• Post-orthopaedic surgery joint rehabilitation support
• Preventive joint care in medium breed dogs at risk of OA (Border Collie, Cocker Spaniel, Bulldog, Boxer, Dalmatian, Siberian Husky, Australian Shepherd)

Dosage

• Administer orally as directed by a licensed veterinarian based on dog body weight
• Confirm weight-based dosing from the Vivaldis Condrovet Force HA Medium Breed product label
• Can be administered directly or crumbled over food
• Cartilage and synovial fluid-supportive effects typically require 4–8 weeks of consistent supplementation before full benefit is visible

Safety Information

• Dietary supplement — administer under veterinary guidance
• Confirm suitability for pregnant, lactating, and breeding animals from product label or veterinarian
• Discontinue if any adverse gastrointestinal reaction is observed; consult a veterinarian
• Keep out of reach of children; store in a cool, dry place away from direct sunlight